2023 NRDL Update: An Ongoing Voyage of Innovation and Accessibility

Home / Intelligence / Webinars / 2023 NRDL Update: An Ongoing Voyage of Innovation and Accessibility

Available On Demand

How can manufacturers strategize for pricing and market access success amidst the evolving landscape of China’s NRDL?

As China continues to be a key pharmaceutical market, understanding the latest National Reimbursement Drug List (NRDL) trends and policy evolvement is crucial for manufacturers aiming to achieve successful access and pricing outcomes. 

In this webinar, a panel of Trinity Life Sciences’ Value, Access and Pricing experts will discuss the role of the new value-based assessment framework in NRDL payer decision-making and dive into the nuances of 2023 NRDL pricing outcomes to inform manufacturer strategies in navigating the dynamic access and pricing landscape in China. 

Key Webinar Topics:

  • Overview of the 2023 China NRDL update: changes, trends and outcomes
  • Case studies of oncology and rare disease drugs: takeaways from success and failure stories
  • Recommendation and outlook for future NRDL updates


Complete the form below to view the on-demand webinar.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.

This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.

Related Intelligence